Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges
2024
Targeting GDF15 Signalling for Obesity Treatment
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Jincheng Zhang, Jingquan Sun, Jielang Li, Hongwei Xia
Primary Institution: West China Hospital Sichuan University
Hypothesis
Is targeting the GDF15-GFRAL signalling pathway an effective approach for treating obesity?
Conclusion
Targeting the GDF15-GFRAL pathway shows promise for obesity treatment with minimal impact on muscle mass.
Supporting Evidence
- Obesity affects 650 million adults worldwide and is linked to various metabolic diseases.
- Targeting the GDF15-GFRAL pathway has shown minimal impact on skeletal muscle mass during weight loss.
- Recent advances in GDF15 analogues have demonstrated potential for obesity treatment.
Takeaway
GDF15 helps control hunger and weight, and scientists are looking at how to use it to help people lose weight without losing muscle.
Methodology
This is a review summarizing recent studies on the GDF15-GFRAL pathway and its implications for obesity treatment.
Limitations
The review does not provide new experimental data and relies on existing studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website